• Tech
• Gadgets
• Mobile
• Enterprise
• CrunchBase
• More
  • Beta Invites
  • Elevator Pitches
  • Gillmor Gang
  • Podcasts
  • TechCrunch50
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Sanofi Aventis

edit

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, provided more than 1.6 billion doses of vaccine in 2008, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines protecting against 20 infectious diseases.

Milestones

edit

• 
  Sanofi Aventis acquired Shantha Biotechnics for $770M. (7/27/09)
  Posted 7/28/09 at 2:48pm
• 
  Sanofi Aventis acquired Merial Limited for $4B. (7/13/09)
  Posted 9/24/09 at 4:50pm
• 
  Sanofi Aventis acquired BiPar Sciences for $500M. (4/15/09)
  Posted 7/28/09 at 2:43pm

Videos

Screenshots

edit

Sources

1. Sanofi snaps up India's Shantha for $784MSanofi snaps up India's Shantha for $784M (fiercebiotech.com) [edit]
2. Citation Needed [add]
3. Sanofi to Buy BiPar Sciences (online.wsj.com) [edit]